Tudor Investment Corporation »

Fulgent Genetics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Fulgent Genetics (FLGT) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Fulgent Genetics

Tip: Access up to 7 years of quarterly data

All positions including Fulgent Genetics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulgent Genetics by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.9M 172k 22.60
2025-06-30 $3.7M 185k 19.88
2025-03-31 $806k 48k 16.90
2024-09-30 $370k 17k 21.73
2021-12-31 $571k 5.7k 100.51
2020-12-31 $525k 10k 52.14

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
Spdr S&P 500 Etf Trust - US ETP ETF Option Call Option (SPY)
Energy Select Sector Spdr Fund - US ETP ETF Option Call Option (XLE)
Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)
Nvidia Corp - US Equity (NVDA)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Unitedhealth Group Inc - US Equity (UNH)
Utilities Select Sector Spdr Fund - US ETP ETF Option Call Option (XLU)
Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)
Palantir Technologies Inc - US Equity (PLTR)
Oracle Corp - US Equity Option Call Option (ORCL)
Micron Technology Inc - US Equity (MU)
Goldman Sachs Group Inc/The - US Equity Option Call Option (GS)
Apple Inc - US Equity (AAPL)

View all positions for Tudor Investment Corporation

Top funds holding Fulgent Genetics

BlackRock
Millennium Management
Vanguard Group
Acadian Asset Management
Dimensional Fund Advisors
D. E. Shaw & Co
Deutsche Bank Aktiengesellschaft
State Street Corporation
Geode Capital Management
Ameriprise Financial
Citadel Advisors
Point72 Asset Management
Charles Schwab Investment Management
Connor, Clark & Lunn Investment Management
Jpmorgan Chase & Co

View all funds holding Fulgent Genetics